Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Cystic Fibrosis Therapeutics Market
Cystic Fibrosis Therapeutics Market Share
- Report ID: GMI5118
- Published Date: Sep 2021
- Report Format: PDF
Cystic Fibrosis Therapeutics Market Share
Some of the prominent companies operating in the market are:
- Vertex Pharmaceutical Incorporated
- Roche
- Nestle Health Science
- AbbVie
- Viatris Inc.
- Horizon Therapeutic Plc.
- Gilead Sciences
- Chiesi Farmacrutici
- Pharmaxis Ltd.
- Teva Pharmaceuticals.
These market participants are implementing various growth strategies to sustain the industry competition.
Frequently Asked Questions (FAQ) :
Global cystic fibrosis therapeutics market size was over USD 8.5 billion during 2020 and is anticipated to register about 16.1% CAGR over 2021-2027.
Medications held nearly USD 6.1 billion share of global cystic fibrosis therapeutics industry in 2020 with increasing demand for mucus thinner, bronchodilators, bronchodilators and other products.
Hospitals are expected to account for almost 49% of cystic fibrosis therapeutics consumption by 2027, with the demand for precise diagnosis and treatments by experienced medical professionals.
North America held around 76% of cystic fibrosis therapeutics industry share during 2020 and the share will expand with high prevalence of the disorder and wider availability of treatment options in the region.
Major companies offering cystic fibrosis therapeutic products worldwide include AbbVie, Gilead Sciences, Roche, Pharmaxis Ltd., Nestle Health Science, and Vertex Pharmaceutical Incorporated, among others.
Cystic Fibrosis Therapeutics Market Scope
×
Get a free sample of
Cystic Fibrosis Therapeutics Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below